# Study to Evaluate the Usability of PointCheck

> **NCT04448314** · — · COMPLETED · sponsor: **Leuko Labs, Inc.** · enrollment: 94 (actual)

## Conditions studied

- Neoplasms
- Chemotherapy-induced Neutropenia

## Interventions

- **DIAGNOSTIC_TEST:** PointCheck

## Key facts

- **NCT ID:** NCT04448314
- **Lead sponsor:** Leuko Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-11
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448314, "Study to Evaluate the Usability of PointCheck". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04448314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*